Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David A Smith

Showing results (101-110 of 119) with videos related to

Pageof 12
Sort By:
Frontiers in Oncology|August 9, 2018
<i>nab</i>-Paclitaxel-Based Therapy in Underserved Patient Populations: The ABOUND.70+ Study in Elderly Patients With Advanced NSCLCCorey J Langer, Edward S Kim, Eric C Anderson, et al.
Physical Review Letters|May 2, 2020
Conductivitylike Gilbert Damping due to Intraband Scattering in Epitaxial IronBehrouz Khodadadi, Anish Rai, Arjun Sapkota, et al.
Wellcome Open Research|April 18, 2023
Defective iron homeostasis and hematological abnormalities in Niemann-Pick disease type C1Oscar C W Chen, Stephan Siebel, Alexandria Colaco, et al.
Cancer Chemotherapy and Pharmacology|November 20, 2020
A Phase Ib multicenter, dose-escalation study of the polyamine analogue PG-11047 in combination with gemcitabine, docetaxel, bevacizumab, erlotinib, cisplatin, 5-fluorouracil, or sunitinib in patients with advanced solid tumors or lymphomaTracy Murray Stewart, Daniel Von Hoff, Michael Fitzgerald, et al.
Mbio|June 27, 2019
Electronic Health Informatics Data To Describe Clearance Dynamics of Hepatitis B Surface Antigen (HBsAg) and e Antigen (HBeAg) in Chronic Hepatitis B Virus InfectionLouise O Downs, David A Smith, Sheila F Lumley, et al.
Journal of Viral Hepatitis|May 18, 2021
Real world SOF/VEL/VOX retreatment outcomes and viral resistance analysis for HCV patients with prior failure to DAA therapyDavid A Smith, Daniel Bradshaw, Jean L Mbisa, et al.
Science Translational Medicine|September 9, 2016
Heat shock protein-based therapy as a potential candidate for treating the sphingolipidosesThomas Kirkegaard, James Gray, David A Priestman, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 8, 2009
Phase II study of eribulin mesylate, a halichondrin B analog, in patients with metastatic breast cancer previously treated with an anthracycline and a taxaneLinda T Vahdat, Brian Pruitt, Carol J Fabian, et al.
Plos One|March 29, 2016
Defective Cytochrome P450-Catalysed Drug Metabolism in Niemann-Pick Type C DiseaseElena-Raluca Nicoli, Nada Al Eisa, Celine V M Cluzeau, et al.
European Journal of Immunology|May 16, 2012
Invariant natural killer T cells are not affected by lysosomal storage in patients with Niemann-Pick disease type CAnneliese O Speak, Nicholas Platt, Mariolina Salio, et al.
Pageof 12

Showing results (101-110 of 119) with videos related to

Sort By:
Pageof 12
Frontiers in Oncology|August 9, 2018
<i>nab</i>-Paclitaxel-Based Therapy in Underserved Patient Populations: The ABOUND.70+ Study in Elderly Patients With Advanced NSCLCCorey J Langer, Edward S Kim, Eric C Anderson, et al.
Physical Review Letters|May 2, 2020
Conductivitylike Gilbert Damping due to Intraband Scattering in Epitaxial IronBehrouz Khodadadi, Anish Rai, Arjun Sapkota, et al.
Wellcome Open Research|April 18, 2023
Defective iron homeostasis and hematological abnormalities in Niemann-Pick disease type C1Oscar C W Chen, Stephan Siebel, Alexandria Colaco, et al.
Cancer Chemotherapy and Pharmacology|November 20, 2020
A Phase Ib multicenter, dose-escalation study of the polyamine analogue PG-11047 in combination with gemcitabine, docetaxel, bevacizumab, erlotinib, cisplatin, 5-fluorouracil, or sunitinib in patients with advanced solid tumors or lymphomaTracy Murray Stewart, Daniel Von Hoff, Michael Fitzgerald, et al.
Mbio|June 27, 2019
Electronic Health Informatics Data To Describe Clearance Dynamics of Hepatitis B Surface Antigen (HBsAg) and e Antigen (HBeAg) in Chronic Hepatitis B Virus InfectionLouise O Downs, David A Smith, Sheila F Lumley, et al.
Journal of Viral Hepatitis|May 18, 2021
Real world SOF/VEL/VOX retreatment outcomes and viral resistance analysis for HCV patients with prior failure to DAA therapyDavid A Smith, Daniel Bradshaw, Jean L Mbisa, et al.
Science Translational Medicine|September 9, 2016
Heat shock protein-based therapy as a potential candidate for treating the sphingolipidosesThomas Kirkegaard, James Gray, David A Priestman, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 8, 2009
Phase II study of eribulin mesylate, a halichondrin B analog, in patients with metastatic breast cancer previously treated with an anthracycline and a taxaneLinda T Vahdat, Brian Pruitt, Carol J Fabian, et al.
Plos One|March 29, 2016
Defective Cytochrome P450-Catalysed Drug Metabolism in Niemann-Pick Type C DiseaseElena-Raluca Nicoli, Nada Al Eisa, Celine V M Cluzeau, et al.
European Journal of Immunology|May 16, 2012
Invariant natural killer T cells are not affected by lysosomal storage in patients with Niemann-Pick disease type CAnneliese O Speak, Nicholas Platt, Mariolina Salio, et al.
Pageof 12